Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAINtenance Afinitor (MAIN-A)
2013-004153-24Phase 3Completed
- Sponsor
- Department of Surgical Oncological and Gastroenterological Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of everolimus in breast cancer (2 arms), sponsored by Department of Surgical Oncological and Gastroenterological Sciences. Primary endpoint: Progression-free survival. Started Mar 2014; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-004153-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004153-24.